Alvotech’s Latest FDA Knockback Cuts It Fine For Humira Rival

AVT02 Adalimumab Biosimilar Receives A Further CRL From US Regulator After Inspection

 
• By David Wallace
  
28 June calendar with red pin
Alvotech’s next key date for AVT02 is 28 June • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products